This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included.
Stroke, Ahead of Print. BACKGROUND:Stroke triggers are factors that may precipitate a stroke within a given time interval and can predict the timing of a stroke. More research is needed to assess the link between the severity of hypoglycemia and stroke occurrence, as well as the severity of the stroke.
Stroke, Volume 56, Issue Suppl_1 , Page ATP146-ATP146, February 1, 2025. Introduction:Differences in risk factors may contribute to disparities in stroke risk. Results:The prevalence of hypertension and diabetes were higher among NHBA than NHWA hospitalized with AIS across all age groups. vs. 82.6%, PR: 1.1).
Stroke, Volume 55, Issue Suppl_1 , Page AWP235-AWP235, February 1, 2024. Introduction:Amid the rising prevalence of cannabis use disorder (CUD) in older adults and with surveys reporting ~85% of overlapping use for medicinal and recreational purposes in American cannabis users, the link between CUD and stroke is paramount. vs. 28.4%).
Stroke, Volume 55, Issue Suppl_1 , Page A13-A13, February 1, 2024. Elderly obese stroke survivors (> 65 years) having a recurrent acute ischemic stroke (AIS), with or without prior bariatric surgery (PBS), were identified using ICD-10 codes. vs. 61.6%), diabetes mellitus (60% vs. 52.2%), tobacco use (37.5%
Stroke, Volume 55, Issue Suppl_1 , Page AWP278-AWP278, February 1, 2024. Background:The current AHA stroke prevention guidelines give Class 1 recommendations that patients with AIS and diabetes should receive glucose-lowering agents with cardiovascular benefit to reduce risk of MACE.
Stroke, Volume 55, Issue Suppl_1 , Page ATP262-ATP262, February 1, 2024. Background:Obesity has been associated with an increase in the risk of stroke and poor outcomes. Meanwhile, Metabolically healthy obesity (MHO) trends are understudied in association with stroke. p<0.001) compared to the MHO+ve cohort.
However, the TACT2 results did not reveal any difference in the composite primary outcome of death from any cause, heart attack, stroke, coronary revascularization or hospitalization for unstable angina among people who received weekly edetate disodium-based infusions compared with those who received a placebo. and Canada.
Stroke, Volume 56, Issue Suppl_1 , Page ATP270-ATP270, February 1, 2025. Introduction:Syphilis is associated with increased risk of cerebrovascular disease and acute stroke; stroke may even be the initial clinical manifestation of syphilis (Images 1 and 2). between 2016-2019, but then dropped to 1.02% in 2020.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Type 2 Diabetes Mellitus (T2DM) is a rapidly growing global health problem with increasing prevalence. from 2016‐2019 and secondary diagnosis of T2DM. Of those patients, 35.43% (n=273,993) were diabetic and 64.57% (n=151,112) were non‐diabetic.
Stroke, Volume 56, Issue Suppl_1 , Page ATP334-ATP334, February 1, 2025. Introduction:Studies have reported racial disparities in acute stroke treatment and follow-up care in young patients which lead to less desirable outcomes for minorities. of young patients had 1 follow-ups at stroke clinic. male, covering 57.2%
Stroke, Volume 56, Issue Suppl_1 , Page AWP141-AWP141, February 1, 2025. Background:A recent prospective study reported that myocardial infarction (MI) was present in nearly half of ischemic stroke patients with substantially elevated troponin, with 1 in 5 having a type 1 MI. In suspected stroke patients, 26.1% (95% CI, 20.9-32.2%)
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionRecombinant tissue plasminogen activator (rtPA) is the only approved treatment for acute ischemic stroke (AIS) patients, however, only a minuscule percentage of patients receive rtPA [1, 2].
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. We aimed to investigate the safety of intravenous tissue plasminogen activator (IV tPA) and mechanical thrombectomy (MT) for acute ischemic stroke (AIS), and compare the functional outcome in cardiomyopathy patients with and without HF.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionSubarachnoid Hemorrhage (SAH) is the leading cause of morbidity and mortality in stroke patients, associated with severe neurological, infectious, and thromboembolic complications. x) from 2016‐2019. x) from 2016‐2019.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionNontraumatic Intracerebral Hemorrhage (ICH) is the second most prevalent type of stroke worldwide and is strongly linked with severe disability and mortality. x) from 2016‐2019 using the Nationwide Readmission Database (NRD).
There were no significant effects on fatal or nonfatal stroke, death from cardiovascular causes and death from any cause. There was no increase in new onset diabetes mellitus or worsening of diabetes mellitus. 2016 Nov 28;7:13457. 6992 patients were assigned to bempedoic acid and 6978 to placebo group. Nat Commun.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP78-ATMP78, February 1, 2024. Patients with a high risk of metabolic syndrome (>= 2 of the following: hypertension, diabetes, hyperlipidemia, or obesity) have a higher risk of AIS (1.37, 1.13 - 1.65), AMI (1.81, 1.19 - 2.75), and MACE (1.28, 1.13 - 1.44).Conclusions:Developing
Stroke, Volume 56, Issue Suppl_1 , Page ATMP1-ATMP1, February 1, 2025. A cerebral aneurysm (CA) is an abnormal artery deformation in the brain that may lead to hemorrhagic stroke, brain damage, coma, and even death when a CA ruptures. We hypothesized that increasing CA sample size will allow more robust biomarker identification.
There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] I think we live in a very exciting time right now for those who work in diabetes and cardiovascular disease.
Stroke, Volume 55, Issue Suppl_1 , Page AWP232-AWP232, February 1, 2024. Patients were followed up for up to 24 weeks postpartum. Patients with migraine (ICD-10 code: G43) before or during pregnancy were considered to have a history of migraine.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP3-AWMP3, February 1, 2025. Intravenous Tenecteplase (TNK) is non-inferior to tPA in the acute treatment of ischemic stroke. Intravenous Tenecteplase (TNK) is non-inferior to tPA in the acute treatment of ischemic stroke. MM patients were older than the thrombolytic patients (74.58.8
In February 2013, the clinical trial known as the PREDIMED Study published in the New England Journal of Medicine produced findings that adhering to a Mediterranean diet reduces the risk of cardiovascular disease by approximately 30% and also reduces the risk of stroke in high-risk patients.
Just for clarity, type 2 diabetes is when insulin resistance progresses to the point that your body can no longer keep your blood glucose levels under control. So if you have type 2 diabetes, you, by definition, are insulin resistant. For each additional feature, the likelihood and likely severity of insulin resistance increases.
Getty Images milla1cf Tue, 03/05/2024 - 13:15 March 5, 2024 — Frequent cannabis smoking may significantly increase a person’s risk for heart attack and stroke, according to an observational study supported by the National Institutes of Health. Less frequent use was also associated with an increased risk of cardiovascular events.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP103-ATMP103, February 1, 2024. Annual percent change (APC) and age-adjusted mortality rates (AAMRs) per 100,000 persons were calculated and stratified by year, sex, and race/ethnicity.Results:From 1999 to 2020 there were 20,941 deaths from ischemic stroke in patients with T2DM.
Stroke, Volume 55, Issue Suppl_1 , Page AWMP86-AWMP86, February 1, 2024. There was a gradual increase in the proportion of MTs performed among mild strokes during study period (10% to 13.5%, p<0.01). of all mild strokes and in 56.9% of strokes with mild deficits following MT. 0.98], P<0.001).Conclusions:In
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionIt is controversial when to pursue carotid artery stenting (CAS) after acute tandem occlusion (TO) strokes treated with endovascular thrombectomy (EVT). CAS performed on day ‐1, 0 or 1 day after admission was considered as emergent CAS.
Stroke, Volume 56, Issue Suppl_1 , Page ADP51-ADP51, February 1, 2025. Background:Migraine with aura (MA) is recognized as an independent risk factor for acute ischemic stroke (AIS). However, the short-term risk of stroke, particularly within 90 days of hospitalization, has not been thoroughly evaluated on a national scale.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. admitted from 2016‐2019 using the Nationwide Readmission Database (NRD). Data was weighted to allow for representative nationwide estimates.ResultsWe identified 1,398 patients admitted with a primary diagnosis of PACNS between 2016 and 2019.
Stroke, Volume 55, Issue Suppl_1 , Page ATP205-ATP205, February 1, 2024. Outcomes included favorable disposition (discharged to home) and in-hospital mortality.Results:Among 68,975 of stroke MT with recorded NIHSS during the study period (51.1% Patient- and hospital-level characteristics were analyzed. women; mean age, 69.1 [SD,
Stroke, Volume 56, Issue 1 , Page 95-104, January 1, 2025. Participants underwent brain magnetic resonance imaging scans every 3 to 4 years between 2005 and 2016. women), large decreases and increases in CBF and increases in CVRi over time were associated with white matter hyperintensity progression.
Stroke, Volume 56, Issue Suppl_1 , Page AWP297-AWP297, February 1, 2025. Background:Existing data indicate recent increases in the prevalence of stroke and relevant risk factors as well as predicted continued increases in coming years.
Stroke, Volume 56, Issue Suppl_1 , Page A73-A73, February 1, 2025. The final models included 1,317 patients with available MRS data and 1,789 patients with available discharge disposition data respectively.
Stroke, Volume 56, Issue Suppl_1 , Page AWP310-AWP310, February 1, 2025. Smoking, diabetes, hypertension, obesity, Black race, age, low education, male sex, and APOEe4 were associated with an increased risk of dementia/no PD. Midlife current smoking (HR 0.41, 95% CI 0.18-0.95,
This misinformation would have resulted in many thousands of people giving up their medication and suffering heart attacks and strokes as a result. I, Dr Malcolm Kendrick, with or without other co-conspirators, would be accused of spreading misinformation about cholesterol and statins. With thousands dying.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content